Mitochondria as Regulators of Nonapoptotic Cell Death in Cancer
MedComm · 2025-08 · 6 (8)
DOI: 10.1002/mco2.70244 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 23.07.2025. Verfasst von Saloni Malla und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Experimental Therapeutics College of Pharmacy and Pharmaceutical Sciences University of Toledo Toledo Ohio USA. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 450 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: U.S. Department of Defense.
Abstract (Originalsprache)
Mitochondria are involved in cell survival and metabolic processes including adenosine triphosphate production, heme biosynthesis, reactive oxygen species, and iron and calcium homeostasis. Although mitochondria are well known to contribute to apoptosis, a growing body of evidence indicates that mitochondria modulate nonapoptotic cell death (NACD) mechanisms, including autophagy, necroptosis, ferroptosis, paraptosis, pyroptosis, parthanatosis, and cuproptosis. These NACD pathways differ in molecular triggers, morphological characteristics, and immunological consequences, but they all involve mitochondria. For example, mitochondrial ROS and lipid peroxidation play a role in ferroptosis, whereas mitochondrial depolarization and the release of apoptosis inducing factor are paramount to parthanatosis. Mitochondrial swelling is a hallmark of paraptosis, whereas mitochondrial disruption is associated with pyroptosis. Autophagy, though primarily a survival mechanism, is also regulated by mitochondrial dynamics in cancer cells. In cuproptosis, mitochondrial protein aggregates when iron–sulfur cluster proteins are disrupted, resulting in copper‐dependent cell death. There are many factors that influence NACD, including mitochondrial membrane potential, bioenergetics, calcium flux, metabolites, and interactions with the endoplasmic reticulum. The review comprehensively summarizes our understanding of mitochondrial and NACD interactions, particularly in cells resistant to classical apoptosis agents. Therapeutic vulnerabilities associated with mitochondria‐mediated NACD could lead to next‐generation therapies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology and Experimental Therapeutics College of Pharmacy and Pharmaceutical Sciences University of Toledo Toledo Ohio USA.
- Department of Pharmaceutical Sciences College of Pharmacy University of Arkansas for Medical Sciences Little Rock Arkansas USA.
- Department of Pharmaceutical Sciences College of Pharmacy St. John's University Queens New York USA.
- Department of Drug Discovery & Development Harrison School of Pharmacy Auburn University Auburn Alabama USA.
Förderung
- U.S. Department of Defense
Zitieren
APA
Malla, S., Neupane, R., Sood, S., Hussein, N., Abou-Dahech, M., Terrero, D., Ashby, C. R., Babu, R. J., & Tiwari, A. K. (2025). Mitochondria as Regulators of Nonapoptotic Cell Death in Cancer. MedComm, 6(8). https://doi.org/10.1002/mco2.70244
Vancouver
Malla S, Neupane R, Sood S, Hussein N, Abou-Dahech M, Terrero D, et al. Mitochondria as Regulators of Nonapoptotic Cell Death in Cancer. MedComm. 2025;6(8). doi:10.1002/mco2.70244
BibTeX
@article{Malla2025,
author = {Malla, Saloni and Neupane, Rabin and Sood, Saloni and Hussein, Noor and Abou-Dahech, Mariam and Terrero, David and Ashby, Charles R and Babu, R Jayachandra and Tiwari, Amit K},
title = {Mitochondria as Regulators of Nonapoptotic Cell Death in Cancer},
journal = {MedComm},
year = {2025},
volume = {6},
number = {8},
doi = {10.1002/mco2.70244}
}
EUVIMED